Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Early-stage methodological work proposing a novel continual learning framework with proof-of-concept experiments on multiple tasks but no clinical or patient outcomes, no comparison to established gold-standard methods, and no peer review.
First-in-kind organoid platform study demonstrating proof-of-concept for modelling vaccine-induced GC reactions in vitro; uncontrolled, single-arm, and lacking clinical validation or comparison to in vivo responses.